COVID-19 convalescent plasma composition and immunological effects in severe patients

Keyphrases

• Antibodies Neutralizing 25%
• Autoantibodies 25%
• B Cells 50%
• Biological Evaluation 25%
• CD4+ 25%
• CD8+ 25%
• Clinical Assessment 25%
• Clinical Parameters 25%
• Composition Effect 100%
• Convalescent Plasma 75%
• Convalescent Plasma Therapy 25%
• COVID-19 25%
• COVID-19 Convalescent Plasma 100%
• Cytokine Profile 25%
• Effector Memory 25%
• Fatty Acyls 25%
• Glycerophospholipids 25%
• Hospitalized Patients 25%
• Immune Response 25%
• Immunoglobulin G 25%
• Immunological Effects 100%
• Interleukin-10 50%
• Interleukin-6 75%
• IP-10 25%
• Latent Autoimmunity 25%
• Lipidomic Profile 25%
• Mechanism of Action 25%
• Memory B Cells 25%
• Memory CD4+ T Cells 25%
• Metabolic Profiling 25%
• Metabolomics 25%
• Nave 25%
• Neutralizing Antibodies 50%
• Nineteen 25%
• Pandemic Control 25%
• Phase Control 25%
• Plasma Composition 100%
• Plasma-induced 25%
• Post-COVID-19 25%
• Posttransfusion 25%
• Pre-pandemic 25%
• Profile Modification 25%
• Recovered COVID-19 Patients 25%
• Recovered Patients 75%
• SARS-CoV-2 Antibodies 75%
• Severe COVID-19 Patients 25%
• Severe Disease 50%
• Severe Patients 100%
• T Cells 50%
• Therapeutic Implications 25%
• Total IgA 25%
• Total IgG 25%
• Total Immunoglobulin 25%
• Viral Load 25%

Immunology and Microbiology

• Autoantibody 12%
• Autoimmunity 12%
• B Cell 25%
• Blood Plasma 100%
• CD4 12%
• CD8 12%
• COVID-19 100%
• Cytokine 25%
• Immune Response 12%
• Immunoglobulin A 25%
• Immunoglobulin G 12%
• Interleukin 10 25%
• Interleukin 6 37%
• Memory B Cell 12%
• Neutralizing Antibody 25%
• Severe Acute Respiratory Syndrome Coronavirus 2 37%
• T Cell 25%
• T-Helper Cell 12%
• Viral Load 12%